<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30810671</article-id><article-id pub-id-type="pmc">6385841</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0202</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Glycated Hemoglobin as a Predictor of the Length of Hospital Stay in
Patients Following Coronary Bypass Graft Surgery in the Saudi
Population</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7827-2047</contrib-id><name><surname>Almogati</surname><given-names>Joud G.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Ahmed</surname><given-names>Elnazeer O.</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD, FRCSI</role></contrib></contrib-group><aff id="aff1">
<label>1</label> Faculty of Medicine, King Abdulaziz University, Kingdom of Saudi
Arabia. </aff><aff id="aff2">
<label>2</label> Cardiac Surgery Department, King Abdullah Medical City, Makkah,
Kingdom of Saudi Arabia. </aff><author-notes><corresp id="c1">Correspondence Address: <bold>Joud G. Almogati</bold>,
http://orcid.org/0000-0001-7827-2047, King Abdulaziz University - Department
Cardiac Surgery, Al-Sulaymaniyah, app258 Al-Sulaymaniyah, Jeddah 21441, Kingdom
of Saudi Arabia. E-mail: <email>joud.almogati@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jan-Feb</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jan-Feb</season><year>2019</year></pub-date><volume>34</volume><issue>1</issue><fpage>28</fpage><lpage>32</lpage><history><date date-type="received"><day>17</day><month>7</month><year>2018</year></date><date date-type="accepted"><day>16</day><month>8</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>The diabetic population has a high prevalence of coronary artery disease, and
frequently patients with diabetes undergo coronary artery bypass graft
(CABG) surgery. Elevated glycated hemoglobin (HbA1c) in diabetics is shown
to be associated with morbidity and mortality, but the association of HbA1c
with postoperative length of hospital stay (LOS) has conflicting results. In
this study, we aim to identify if elevated HbA1c levels are associated with
prolonged LOS after CABG surgery.</p></sec><sec><title>Methods</title><p>A retrospective chart review study was performed, using a total of 305
patients who were referred for CABG surgery. HbA1c levels were measured
before the day of surgery. Patients were classified into two groups
according to HbA1c levels: &#x0003c;7% and &#x02265;7%. A LOS of more than 14 days
was proposed as an extended LOS. HbA1c and the LOS relationship were
assessed using appropriate statistical methods.</p></sec><sec><title>Results</title><p>Patients who had diabetes mellitus comprised 81.6% of our studied population.
Sixty-four percent had HbA1c levels &#x02265; 7%. There was no significant
difference in the total LOS in HbA1c &#x0003c;7% compared to HbA1c &#x02265;7%
patients (<italic>P</italic>=0.367).</p></sec><sec><title>Conclusion</title><p>Our study results rejected the proposed hypothesis that elevated HbA1c levels
&#x02265;7% would be associated with prolonged hospital stay following CABG
surgery in a Saudi population.</p></sec></abstract><kwd-group><kwd>Myocardial Revascularization</kwd><kwd>Length of Stay</kwd><kwd>Glycated Hemoglobin</kwd></kwd-group></article-meta></front><body><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
graft</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">HbA1c</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Hemoglobin A1c or
glycated hemoglobin</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">HPLC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= High pressure liquid
chromatography</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ICU</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Intensive care unit</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LOS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Length of hospital
stay</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LVEF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left ventricular
ejection fraction</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">NYHA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= New York Heart
Association</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Standard deviation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">STS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Society of Thoracic
Surgeons</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>There are 425 million people with diabetes in the world, and this prevalence is
estimated to reach 629 million in the year of 2045<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. The reported prevalence
of diabetes in Saudi Arabia is high, at about 30%<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Overall, vascular
diseases, which include coronary heart disease and cerebrovascular disease, account
for 65% of all deaths among diabetic patients<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>, and this mortality is related to the
baseline HbA1c level<sup>[<xref rid="r4" ref-type="bibr">4</xref>-<xref rid="r6" ref-type="bibr">6</xref>]</sup>.</p><p>Plasma hemoglobin A1c (HbA1c) reflects mean ambient fasting and postprandial glycemia
over the preceding 2-3 months. It is formed by the slow irreversible, non-enzymatic
glycation of valine and lysine residues in the hemoglobin
molecule<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p><p>Coronary heart disease is common in the diabetic population, and frequently patients
with diabetes need coronary artery bypass graft (CABG) surgery<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. Within the United
States alone, approximately 500,000 patients undergo CABG surgery annually, of whom
20% have diabetes mellitus<sup>[<xref rid="r9" ref-type="bibr">9</xref>-<xref rid="r11" ref-type="bibr">11</xref>]</sup>. The reported incidence in Saudi Arabia of CABG in
patients who have diabetes is 61.2% and 78.8% for males and females,
respectively<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>.</p><p>Prevalence of high HbA1c is common among patients undergoing CABG
surgery<sup>[<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r14" ref-type="bibr">14</xref>]</sup>, and it was found to be a risk marker for this
surgery<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>. Additionally, elevated HbA1c levels preceding CABG
surgery are strongly related to the severity of subsequent complications, such as
in-hospital death, renal failure<sup>[<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r16" ref-type="bibr">16</xref>]</sup>, myocardial infarction, cerebrovascular accident,
and deep sternal wound infection<sup>[<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r17" ref-type="bibr">17</xref>]</sup>. Hyperglycemia before surgery was found to be
associated with an increased risk for complications after surgery. Additionally,
controlling hyperglycemia after cardiac surgery was shown to decrease the rate of
deep sternal wound infection<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>, myocardial ischemia, and other
complications<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>.</p><p>Previous reports about the influence of poor long-term glycemic control on
postoperative length of hospital stay (LOS) have conflicting
results<sup>[<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r20" ref-type="bibr">20</xref>-<xref rid="r24" ref-type="bibr">24</xref>]</sup>.</p><p>Our study aims to establish if HbA1c levels can predict LOS in diabetic patients
after CABG surgery.</p></sec><sec sec-type="methods"><title>METHODS</title><p>A retrospective chart review study was performed, using 315 patients who were
referred for CABG surgery at King Abdullah medical city (Makkah, Saudi Arabia) from
November 2013 to May 2015. Of the 315 patients, 10 patients had incomplete data,
such as missing HbA1c levels, and they were not included in the study. The final
population consisted of 305 patients, and the cardiac surgery department database
was used to retrieve patient data. The Institutional Review Board approved the study
and waved the need for individual patient consent.</p><p>The clinical data included in our study were: age, sex, body mass index, New York
Heart Association (NYHA) functional class, number of diseased vessels, and left
ventricular ejection fraction (LVEF). The patients' history of diabetes mellitus,
hypertension, dyslipidemia, history of peripheral vascular disease, and
post-operative complications was also noted.</p><p>HbA1c levels were measured on the day of surgery or within 3 days before the
operation using high pressure liquid chromatography (HPLC). Patients were classified
into the following two groups based on their HbA1c levels: &#x0003c;7% and &#x02265;7%. A
HbA1c level &#x02265;7% was used as the threshold for uncontrolled hyperglycemia,
because this level is recognized by the American Diabetes Association as
representing poor diabetes control<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>. A LOS of more than 14 days was proposed as an
extended LOS, as defined by the Society of Thoracic Surgeons
(STS)<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup>.</p><sec><title>Statistical Analysis</title><p>Categorized variables were presented as percentages and frequencies, while the
quantitative variables are given as the mean &#x000b1; standard deviation (SD).
The relationship between HbA1c and LOS was assessed using Pearson's Chi-square
test. Clinical characteristics and morbidities were analyzed using an
independent t-test and Pearson's Chi-square test where appropriate to determine
the predictors of LOS. The variables were entered into a logistic regression
model according to their statistical significance.</p><p>SPSS Version 16 for Windows (SPSS, Inc., Chicago, IL, USA) was used for
statistical analysis. A <italic>P</italic>-value of &#x0003c;0.05 was assumed to
represent statistical significance.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>The clinical characteristics and preoperative data for patients are presented in
<xref rid="t1" ref-type="table">Table 1</xref>. Patients who had diabetes
mellitus comprised 81.6% (249/305) of our studied population, with a mean age 59.1
years (range, 31-87 years). The range of HbA1c was 4.9%-15%, and 64% (195/305) had
HbA1c levels &#x02265;7%. Of those patients, 96.4% (188/195) were known to have
diabetes.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Clinical characteristics of CABG patients (all patients n=305).</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="60%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Clinical characteristics</th><th align="center" rowspan="1" colspan="1">Results</th></tr></thead><tbody><tr><td align="left" colspan="2" rowspan="1">Mean age (year), (SD)</td><td align="center" rowspan="1" colspan="1">59.10 (&#x000b1; 9.67)</td></tr><tr><td align="left" colspan="2" rowspan="1">Male sex, n (%)</td><td align="center" rowspan="1" colspan="1">250 (82)</td></tr><tr><td align="left" colspan="2" rowspan="1">Mean body mass index (kg/m<sup>2</sup>),
(SD)</td><td align="center" rowspan="1" colspan="1">27.80 (&#x000b1;5.88)</td></tr><tr><td align="left" colspan="2" rowspan="1">Diabetes mellitus, n (%)</td><td align="center" rowspan="1" colspan="1">249 (81.6)</td></tr><tr><td align="left" colspan="2" rowspan="1">Hypertension, n (%)</td><td align="center" rowspan="1" colspan="1">256 (83.9)</td></tr><tr><td align="left" colspan="2" rowspan="1">Dyslipidemia, n (%)</td><td align="center" rowspan="1" colspan="1">143 (46.9)</td></tr><tr><td align="left" colspan="2" rowspan="1">History of PVD, n (%)</td><td align="center" rowspan="1" colspan="1">9 (3)</td></tr><tr><td align="left" rowspan="4" colspan="1">NYHA functional class, n (%)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2(0.7)</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">164 (53.4)</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">109 (35.7)</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">30 (9.8)</td></tr><tr><td align="left" rowspan="3" colspan="1">Number of diseased vessels, n (%)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">3 (1)</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">32 (10.5)</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">270 (88.5)</td></tr><tr><td align="left" colspan="2" rowspan="1">Left ventricular ejection fraction % mean
(range)</td><td align="center" rowspan="1" colspan="1">43.7 (15-68)</td></tr><tr><td align="left" colspan="2" rowspan="1">Patients with HbA1c &#x02265;7%, n (%)</td><td align="center" rowspan="1" colspan="1">195 (63.9)</td></tr><tr><td align="left" colspan="2" rowspan="1">Mean HbA1c, (SD)</td><td align="center" rowspan="1" colspan="1">8.2 (&#x000b1;2.16)</td></tr><tr><td align="left" colspan="2" rowspan="1">Mean EuroSCORE, (SD)</td><td align="center" rowspan="1" colspan="1">4.3 (&#x000b1;4.25)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>HbA1c=glycated hemoglobin; NYHA=New York Heart Association;
PVD=peripheral vascular disease; SD=standard deviation</p></fn></table-wrap-foot></table-wrap><p>Complications are presented in <xref rid="t2" ref-type="table">Table 2</xref>. A
total of 100 patients out of 305 (32.78%) had postoperative complications within 30
days. The most frequent complications were atrial fibrillation (31.85%, 97/305) and
renal failure (5.2%, 16/305). Twelve (3.93%) patients died, and their mean EuroSCORE
was 8.82 (range, 1.05 to 26.24). Twelve (3.9%) patients developed mediastinitis, and
nine of them were diabetic. Postoperative LOS ranged from 2 to 90 days (mean, 11.77
&#x000b1; 11.86 days), with a median of 8 days. Sixty-seven percent of patients
(204/305) had a LOS &#x02264;10 days, 21% of patients (64/305) had LOS &#x02265;14
days, and only 3.6% of patients (11/305) had LOS &#x02265;40 days.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Postoperative morbidity and mortality (all patients n=305).</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="60%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Events</th><th align="center" rowspan="1" colspan="1">Number</th><th align="center" rowspan="1" colspan="1">Percent (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Postoperative deaths</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">3.93</td></tr><tr><td align="left" rowspan="1" colspan="1">Atrial fibrillation</td><td align="center" rowspan="1" colspan="1">97</td><td align="center" rowspan="1" colspan="1">31.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Cerebrovascular accident</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Renal impairment</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">5.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Surgical site infection</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">3.9</td></tr></tbody></table></table-wrap><p><xref rid="t3" ref-type="table">Table 3</xref> presents surgical outcomes related to
preoperative HbA1c levels (with HbA1c &#x0003c;7% compared to HbA1c &#x02265;7%). There is
no correlation between increased HbA1c levels and 30-day mortality rates,
arrhythmia, cerebrovascular accident, renal failure requiring dialysis, or
mediastinitis.</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Comparison of postoperative morbidity and mortality with preoperative HbA1c
levels.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">HbA1c &#x0003c;7% (n=110)</th><th align="center" rowspan="1" colspan="1">HbA1c &#x02265;7% (n=195)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Postoperative deaths</td><td align="center" rowspan="1" colspan="1">3 (0.9%)</td><td align="center" rowspan="1" colspan="1">12 (6.2%)</td><td align="center" rowspan="1" colspan="1">0.409</td></tr><tr><td align="left" rowspan="1" colspan="1">Arrhythmia</td><td align="center" rowspan="1" colspan="1">30 (27.3%)</td><td align="center" rowspan="1" colspan="1">67 (34.4%)</td><td align="center" rowspan="1" colspan="1">0.202</td></tr><tr><td align="left" rowspan="1" colspan="1">Cerebrovascular accident</td><td align="center" rowspan="1" colspan="1">1 (0.9%)</td><td align="center" rowspan="1" colspan="1">5 (0.5%)</td><td align="center" rowspan="1" colspan="1">0.600</td></tr><tr><td align="left" rowspan="1" colspan="1">Renal failure requiring dialysis</td><td align="center" rowspan="1" colspan="1">5 (4.5%)</td><td align="center" rowspan="1" colspan="1">12 (6.2%)</td><td align="center" rowspan="1" colspan="1">0.680</td></tr><tr><td align="left" rowspan="1" colspan="1">Mediastinitis</td><td align="center" rowspan="1" colspan="1">3 (0.9%)</td><td align="center" rowspan="1" colspan="1">9 (2.9%)</td><td align="center" rowspan="1" colspan="1">0.415</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>Level of significance, <italic>P</italic>&#x0003c;0.05. HbA1c=glycated
hemoglobin</p></fn></table-wrap-foot></table-wrap><p><xref rid="t4" ref-type="table">Table 4</xref> presents the predictors of CABG
surgery LOS, and there was no significant difference in HbA1c &#x0003c;7% compared to
HbA1c &#x02265;7 for total LOS using Pearson's Chi-square test
<italic>(P</italic>=0.367). Using the independent t-test, LVEF% was the only
predictor of LOS to reach statistical significance (<italic>P</italic>=0.001).
Additionally, the logistic regression analysis for LVEF% and LOS (&#x0003c;14 days,
&#x02265;14 days) was significant (<italic>P</italic>&#x02264;0.001).</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Predictors of length of hospital stay post coronary artery bypass graft
surgery.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Variables</th><th align="center" rowspan="1" colspan="1">LOS &#x0003c; 14 days (n=241)</th><th align="center" rowspan="1" colspan="1">LOS &#x02265; 14 days (n=64)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="2" rowspan="1">Age</td><td align="center" rowspan="1" colspan="1">59.1 &#x000b1;9.7</td><td align="center" rowspan="1" colspan="1">58.9 &#x000b1;9.3</td><td align="center" rowspan="1" colspan="1">0.856</td></tr><tr><td align="left" colspan="2" rowspan="1">Male sex</td><td align="center" rowspan="1" colspan="1">200 (74)</td><td align="center" rowspan="1" colspan="1">50 (78)</td><td align="center" rowspan="1" colspan="1">0.368</td></tr><tr><td align="left" colspan="2" rowspan="1">Diabetes mellitus</td><td align="center" rowspan="1" colspan="1">196 (81.3)</td><td align="center" rowspan="1" colspan="1">53 (82.8)</td><td align="center" rowspan="1" colspan="1">0.785</td></tr><tr><td align="left" colspan="2" rowspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">203 (84.2)</td><td align="center" rowspan="1" colspan="1">53 (82.8)</td><td align="center" rowspan="1" colspan="1">0.783</td></tr><tr><td align="left" colspan="2" rowspan="1">Dyslipidemia</td><td align="center" rowspan="1" colspan="1">111 (46)</td><td align="center" rowspan="1" colspan="1">32 (50)</td><td align="center" rowspan="1" colspan="1">0.574</td></tr><tr><td align="left" colspan="2" rowspan="1">PVD history</td><td align="center" rowspan="1" colspan="1">6 (2.5)</td><td align="center" rowspan="1" colspan="1">3 (4.6)</td><td align="center" rowspan="1" colspan="1">0.356</td></tr><tr><td align="left" rowspan="4" colspan="1">NYHA functional class</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2 (0.8)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.724</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">129 (53.5)</td><td align="center" rowspan="1" colspan="1">35 (54.6)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">88 (36.5)</td><td align="center" rowspan="1" colspan="1">21 (32.8)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">22 (9.1)</td><td align="center" rowspan="1" colspan="1">8 (12.5)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="3" colspan="1">Number of diseased vessels</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">3 (1.2)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.665</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">25 (10.3)</td><td align="center" rowspan="1" colspan="1">7 (10.9)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">213 (88.4)</td><td align="center" rowspan="1" colspan="1">57 (89)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">LVEF %</td><td align="center" rowspan="1" colspan="1">44.8 &#x000b1;9.3</td><td align="center" rowspan="1" colspan="1">39.6 &#x000b1;9.9</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="2" colspan="1">HbA1c</td><td align="center" rowspan="1" colspan="1">&#x0003c; 7%</td><td align="center" rowspan="1" colspan="1">90 (37.3)</td><td align="center" rowspan="1" colspan="1">20 (31.3)</td><td align="center" rowspan="1" colspan="1">0.367</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02265; 7%</td><td align="center" rowspan="1" colspan="1">151 (62.6)</td><td align="center" rowspan="1" colspan="1">44 (68.8)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>Data are presented as the mean &#x000b1;SD or n (%)</p><p>HbA1c=glycated hemoglobin; LOS=Length of hospital stay; LVEF=left
ventricular ejection fraction; NYHA = New York Heart Association;
PVD=peripheral vascular disease</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>In this study of 305 patients, we investigated as to whether those with elevated
HbA1c levels had a longer LOS compared with those with optimal HbA1c levels CABG. We
found that LOS was not affected by preoperative HbA1c levels (with a cut-off point
of HbA1c = 7% for optimal and suboptimal levels; <italic>P</italic>=0.367). This is
in agreement with the results of previous studies that investigated the above
relationship<sup>[<xref rid="r21" ref-type="bibr">21</xref>,<xref rid="r22" ref-type="bibr">22</xref>]</sup>. Knapik et al.<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup> reported a study in
2010 with a population of 782 diabetic patients, which showed no significant
difference in total LOS (with HbA1c &#x02264;7% compared to HbA1c &#x0003e;7%;
<italic>P</italic>=0.59). Matsuura et al.<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup> reported similar results in a study in
2009.</p><p>Conversely, Medhi et al.<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup> conducted a study in 2001 with 135 patients,
showing that HbA1c was significantly associated with postoperative LOS
<italic>(P</italic>=0.025), while in a 2012 study by Najafi et
al.<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>, similar results were found
(<italic>P</italic>=0.01). These disparities may be a result of different cut-off
points to define a prolonged hospital stay (from &#x02265;3 to 7
days)<sup>[<xref rid="r20" ref-type="bibr">20</xref>,<xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r23" ref-type="bibr">23</xref>]</sup>, different sample sizes, and different study
populations.</p><p>Postoperative LOS ranged from 2 to 90 days (mean, 11.77 &#x000b1; 11.86 days) with a
median of 8 days. This is longer than the post-CABG LOS that was reported by
others<sup>[<xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r23" ref-type="bibr">23</xref>]</sup>.</p><p>We found that the LVEF can predict LOS following CABG (<italic>P</italic>=0.001).
Najafi et al. <sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup> reported that LVEF was not a significant predictor
of LOS, but their findings were only for intensive care unit (ICU) LOS, and not for
the overall length of hospital stay. The most common complication was atrial
fibrillation, which was observed in about 32% of patients. This is similar to
results reported in previous studies<sup>[<xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r23" ref-type="bibr">23</xref>]</sup>. There was no significant difference in the
post-operative complication rate between HbA1c &#x0003c;7% and HbA1c &#x02265;7%. A study
in 2017 by Finger et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup> showed similar results, except that sternal wound
infections were significantly increased in the HbA1c &#x02265;7% group
(<italic>P</italic>=0.030).</p><p>In diabetics scheduled for CABG, poor preoperative glycemic control (suggested by
HbA1c) is common, and 64% of our population had HbA1c &#x02265;7%.</p><p>To our knowledge, this study is the first to present data on the prevalence of
elevated HbA1c in patients undergoing CABG, and its relation to LOS in Saudi
Arabia.</p><p>The limitations of this study were that it was conducted at one health center, which
may limit its generalizability, and its retrospective nature; not all the
information was available as a result of poor documentation because the data was
recorded in the past. However, there was a sufficiently large sample size for our
purposes.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Our study results rejected the proposed hypothesis that elevated HbA1c levels &#x0003e;7%
would be associated with a prolonged hospital stay following CABG surgery in a Saudi
population.</p><table-wrap id="t6" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">JGA</td><td align="left" rowspan="1" colspan="1">Contributions to the design, acquisition,
interpretation of data and drafting the work; final approval of the
version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">EOA</td><td align="left" rowspan="1" colspan="1">Contributions to the design, acquisition,
interpretation of data and drafting the work; final approval of the
version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Cardiac Surgery Department, King Abdullah
Medical City, Makkah, Kingdom of Saudi Arabia.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="webpage"><person-group person-group-type="editor"><collab>International Diabetes Federation</collab></person-group><year>2017</year><source>International diabetes atlas</source><edition>8thth ed</edition><date-in-citation content-type="access-date">2018 June 12</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.diabetesatlas.org/across-the-globe.html">http://www.diabetesatlas.org/across-the-globe.html</ext-link></comment></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alqurashi</surname><given-names>KA</given-names></name><name><surname>Aljabri</surname><given-names>KS</given-names></name><name><surname>Bokhari</surname><given-names>SA</given-names></name></person-group><article-title>Prevalence of diabetes mellitus in a Saudi
community</article-title><source>Ann Saudi Med</source><year>2011</year><volume>31</volume><issue>1</issue><fpage>19</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">21245594</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Geiss</surname><given-names>LS</given-names></name><name><surname>Herman</surname><given-names>WH</given-names></name><name><surname>Smith</surname><given-names>PJ</given-names></name><collab>National Diabetes Data Group</collab></person-group><source>Diabetes in America</source><year>1995</year><publisher-loc>Bethesda</publisher-loc><publisher-name>National Institutes of Health, National Institute of Diabetes
and Digestive and Kidney Diseases</publisher-name></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Chan</surname><given-names>WM</given-names></name><name><surname>Hui</surname><given-names>YF</given-names></name><name><surname>Lam</surname><given-names>TH</given-names></name></person-group><article-title>Association between HbA1c and cardiovascular disease mortality in
older Hong Kong Chinese with diabetes</article-title><source>Diabet Med</source><year>2012</year><volume>29</volume><issue>3</issue><fpage>393</fpage><lpage>398</lpage><pub-id pub-id-type="pmid">21916977</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>RC</given-names></name><name><surname>Millns</surname><given-names>H</given-names></name><name><surname>Neil</surname><given-names>HA</given-names></name><name><surname>Stratton</surname><given-names>IM</given-names></name><name><surname>Manley</surname><given-names>SE</given-names></name><name><surname>Mathews</surname><given-names>DR</given-names></name><etal/></person-group><article-title>Risk factors for coronary artery disease in non-insulin dependent
diabetes mellitus: United Kingdom Prospective Diabetes Study
(UKPDS:23)</article-title><source>BMJ</source><year>1998</year><volume>316</volume><issue>7134</issue><fpage>823</fpage><lpage>828</lpage><pub-id pub-id-type="pmid">9549452</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saydah</surname><given-names>S</given-names></name><name><surname>Tao</surname><given-names>M</given-names></name><name><surname>Imperatore</surname><given-names>G</given-names></name><name><surname>Gregg</surname><given-names>E</given-names></name></person-group><article-title>GHb level and subsequent mortality among adults in the
U.S.</article-title><source>Diabetes Care</source><year>2009</year><volume>32</volume><issue>8</issue><fpage>1440</fpage><lpage>1446</lpage><pub-id pub-id-type="pmid">19401445</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnamurti</surname><given-names>U</given-names></name><name><surname>Steffes</surname><given-names>MW</given-names></name></person-group><article-title>Glycohemoglobin: a primary predictor of the development or
reversal of complications of diabetes mellitus</article-title><source>Clin Chem</source><year>2001</year><volume>47</volume><issue>7</issue><fpage>1157</fpage><lpage>1165</lpage><pub-id pub-id-type="pmid">11427445</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Skyler</surname><given-names>JS</given-names></name></person-group><chapter-title>Relationship of glycemic control to diabetic
complication</chapter-title><person-group person-group-type="editor"><name><surname>Porte</surname><given-names>DJ</given-names></name><name><surname>Sherwin</surname><given-names>RS</given-names></name></person-group><source>Ellenberg &#x00026; Rifkin's diabetes mellitus</source><year>1996</year><publisher-loc>Stamford</publisher-loc><publisher-name>Appleton and Lange</publisher-name><fpage>1235</fpage><lpage>1254</lpage></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halkos</surname><given-names>ME</given-names></name><name><surname>Puskas</surname><given-names>JD</given-names></name><name><surname>Lattouf</surname><given-names>OM</given-names></name><name><surname>Kilgo</surname><given-names>P</given-names></name><name><surname>Kerendi</surname><given-names>F</given-names></name><name><surname>Song</surname><given-names>HK</given-names></name><etal/></person-group><article-title>Elevated preoperative hemoglobin A1c level is predictive of
adverse events after coronary artery bypass surgery</article-title><source>J Thorac Cardiovasc Surg</source><year>2008</year><volume>136</volume><issue>3</issue><fpage>631</fpage><lpage>640</lpage><pub-id pub-id-type="pmid">18805264</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halkos</surname><given-names>ME</given-names></name><name><surname>Lattouf</surname><given-names>OM</given-names></name><name><surname>Puskas</surname><given-names>JD</given-names></name><name><surname>Kilgo</surname><given-names>P</given-names></name><name><surname>Cooper</surname><given-names>WA</given-names></name><name><surname>Morris</surname><given-names>CD</given-names></name><etal/></person-group><article-title>Elevated preoperative hemoglobin A1c level is associated with
reduced long-term survival after coronary artery bypass
surgery</article-title><source>Ann Thorac Surg</source><year>2008</year><volume>86</volume><issue>5</issue><fpage>1431</fpage><lpage>1437</lpage><pub-id pub-id-type="pmid">19049726</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estrada</surname><given-names>CA</given-names></name><name><surname>Young</surname><given-names>JA</given-names></name><name><surname>Nifong</surname><given-names>LW</given-names></name><name><surname>Chitwood Jr</surname><given-names>WR</given-names></name></person-group><article-title>Outcomes and perioperative hyperglycemia in patients with or
without diabetes mellitus undergoing coronary artery bypass
grafting</article-title><source>Ann Thorac Surg</source><year>2003</year><volume>75</volume><issue>5</issue><fpage>1392</fpage><lpage>1399</lpage><pub-id pub-id-type="pmid">12735552</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>M</given-names></name><name><surname>Arifi</surname><given-names>AA</given-names></name><name><surname>Onselen</surname><given-names>Rv</given-names></name><name><surname>Alkodami</surname><given-names>AA</given-names></name><name><surname>Zaibag</surname><given-names>M</given-names></name><name><surname>Khaldi</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Gender differences in the surgical management and early clinical
outcome of coronary artery disease: single centre experience</article-title><source>J Saudi Heart Assoc</source><year>2010</year><volume>22</volume><issue>2</issue><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">23960594</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engoren</surname><given-names>M</given-names></name><name><surname>Habib</surname><given-names>RH</given-names></name><name><surname>Zacharias</surname><given-names>A</given-names></name><name><surname>Schwann</surname><given-names>TA</given-names></name><name><surname>Riordan</surname><given-names>CJ</given-names></name><name><surname>Durham</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>The prevalence of elevated hemoglobin A1c in patients undergoing
coronary artery bypass surgery</article-title><source>J Cardiothorac Surg</source><year>2008</year><volume>3</volume><fpage>63</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">19025628</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alserius</surname><given-names>T</given-names></name><name><surname>Anderson</surname><given-names>RE</given-names></name><name><surname>Hammar</surname><given-names>N</given-names></name><name><surname>Nordqvist</surname><given-names>T</given-names></name><name><surname>Ivert</surname><given-names>T</given-names></name></person-group><article-title>Elevated glycosylated haemoglobin (HbA1c) is a risk marker in
coronary artery bypass surgery</article-title><source>Scand Cardiovasc J</source><year>2008</year><volume>42</volume><issue>6</issue><fpage>392</fpage><lpage>398</lpage><pub-id pub-id-type="pmid">18609043</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alserius</surname><given-names>T</given-names></name><name><surname>Hammar</surname><given-names>N</given-names></name><name><surname>Nordqvist</surname><given-names>T</given-names></name><name><surname>Ivert</surname><given-names>T</given-names></name></person-group><article-title>Improved survival after coronary artery bypass grafting has not
influenced the mortality disadvantage in patients with diabetes
mellitus</article-title><source>J Thorac Cardiovasc Surg</source><year>2009</year><volume>138</volume><issue>5</issue><fpage>1115</fpage><lpage>1122</lpage><pub-id pub-id-type="pmid">19837217</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>C</given-names></name><name><surname>Welsby</surname><given-names>I</given-names></name><name><surname>Phillps-Bute</surname><given-names>B</given-names></name><name><surname>Mathew</surname><given-names>JP</given-names></name><name><surname>Lutz</surname><given-names>A</given-names></name><name><surname>Chad Hughes</surname><given-names>G</given-names></name><etal/><collab>Cardiothoracic Anesthesiology Research Endeavors (C.A.R.E.)
Group</collab></person-group><article-title>Glycosylated hemoglobin levels and outcome in non-diabetic
cardiac surgery patients</article-title><source>Can J Anesth</source><year>2010</year><volume>57</volume><issue>6</issue><fpage>565</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">20221858</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finger</surname><given-names>B</given-names></name><name><surname>Brase</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Gibson</surname><given-names>WJ</given-names></name><name><surname>Wirtz</surname><given-names>K</given-names></name><name><surname>Flynn</surname><given-names>BC</given-names></name></person-group><article-title>Elevated hemoglobin A1c is associated with lower socioeconomic
position and increased postoperative infections and longer hospital stay
after cardiac surgical procedures</article-title><source>Ann Thorac Surg</source><year>2017</year><volume>103</volume><issue>1</issue><fpage>145</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">27553502</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zerr</surname><given-names>KJ</given-names></name><name><surname>Furnary</surname><given-names>AP</given-names></name><name><surname>Grunkemeier</surname><given-names>GL</given-names></name><name><surname>Bookin</surname><given-names>S</given-names></name><name><surname>Kanhere</surname><given-names>V</given-names></name><name><surname>Starr</surname><given-names>A</given-names></name></person-group><article-title>Glucose control lowers the risk of wound infection in diabetics
after open heart operations</article-title><source>Ann Thorac Surg</source><year>1997</year><volume>63</volume><issue>2</issue><fpage>356</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">9033300</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazar</surname><given-names>HL</given-names></name><name><surname>Chipkin</surname><given-names>SR</given-names></name><name><surname>Fitzgerald</surname><given-names>CA</given-names></name><name><surname>Bao</surname><given-names>Y</given-names></name><name><surname>Cabral</surname><given-names>H</given-names></name><name><surname>Apstein</surname><given-names>CS</given-names></name></person-group><article-title>Tight glycemic control in diabetic coronary artery bypass graft
patients improves perioperative outcomes and decreases recurrent ischemic
events</article-title><source>Circulation</source><year>2004</year><volume>109</volume><issue>12</issue><fpage>1497</fpage><lpage>1502</lpage><pub-id pub-id-type="pmid">15006999</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knapik</surname><given-names>P</given-names></name><name><surname>Ciesla</surname><given-names>D</given-names></name><name><surname>Filipiak</surname><given-names>K</given-names></name><name><surname>Knapik</surname><given-names>M</given-names></name><name><surname>Zembala</surname><given-names>M</given-names></name></person-group><article-title>Prevalence and clinical significance of elevated preoperative
glycosylated hemoglobin in diabetic patients scheduled for coronary artery
surgery</article-title><source>Eur J Cardiothorac Surg</source><year>2011</year><volume>39</volume><issue>4</issue><fpage>484</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">21087870</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuura</surname><given-names>K</given-names></name><name><surname>Imamaki</surname><given-names>M</given-names></name><name><surname>Ishida</surname><given-names>A</given-names></name><name><surname>Shimura</surname><given-names>H</given-names></name><name><surname>Niitsuma</surname><given-names>Y</given-names></name><name><surname>Miyazaki</surname><given-names>M</given-names></name></person-group><article-title>Off-pump coronary artery bypass grafting for poorly controlled
diabetic patients</article-title><source>Ann Thorac Cardiovasc Surg</source><year>2009</year><volume>15</volume><issue>1</issue><fpage>18</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">19262445</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Najafi</surname><given-names>M</given-names></name><name><surname>Goodarzynejad</surname><given-names>H</given-names></name></person-group><article-title>Determinants of length of stay in surgical ward after coronary
bypass surgery: glycosylated hemoglobin as a predictor in all patients,
diabetic or non-diabetic</article-title><source>J Tehran Heart Cent</source><year>2012</year><volume>7</volume><issue>4</issue><fpage>170</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">23323078</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medhi</surname><given-names>M</given-names></name><name><surname>Marshall Jr</surname><given-names>MC</given-names></name><name><surname>Burke</surname><given-names>HB</given-names></name><name><surname>Hasan</surname><given-names>R</given-names></name><name><surname>Nayak</surname><given-names>D</given-names></name><name><surname>Reed</surname><given-names>G</given-names></name><etal/></person-group><article-title>HbA1c predicts length of stay in patients admitted for coronary
artery bypass surgery</article-title><source>Heart Dis</source><year>2001</year><volume>3</volume><issue>2</issue><fpage>77</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">11975774</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omar</surname><given-names>AS</given-names></name><name><surname>Salama</surname><given-names>A</given-names></name><name><surname>Allam</surname><given-names>M</given-names></name><name><surname>Elgohary</surname><given-names>Y</given-names></name><name><surname>Mohammed</surname><given-names>S</given-names></name><name><surname>Tuli</surname><given-names>AK</given-names></name><etal/></person-group><article-title>Association of time in blood glucose range with outcomes
following cardiac surgery</article-title><source>BMC Anesthesiol</source><year>2015</year><volume>15</volume><fpage>14</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">25670921</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="webpage"><person-group person-group-type="editor"><collab>ADA Diabetes Guidelines Glycemic Targets A1C | NDEI</collab></person-group><year>2017</year><comment>[online]</comment><source>Ndei.org</source><date-in-citation content-type="access-date">2018 June 12</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ndei.org/ADA-diabetes-management-guidelines-glycemic-targets-A1C-PG.aspx">http://www.ndei.org/ADA-diabetes-management-guidelines-glycemic-targets-A1C-PG.aspx</ext-link></comment></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="webpage"><person-group person-group-type="editor"><collab>Society of Thoracic Surgeons</collab></person-group><source>Quality performance measures</source><date-in-citation content-type="access-date">2018 June 12</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.sts.org/quality-research-patient-safety/quality/quality-performance-measures">http://www.sts.org/quality-research-patient-safety/quality/quality-performance-measures</ext-link></comment></element-citation></ref></ref-list></back></article>